Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Preliminary results
Quarterly results
Director departure
Appointed director
CC transcript

Alexza Pharmaceuticals Inc. (ALXA) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/16/2018 CT ORDER Form CT ORDER - Confidential treatment order:
01/16/2018 CT ORDER Form CT ORDER - Confidential treatment order:
03/31/2017 CT ORDER Form CT ORDER - Confidential treatment order
03/31/2017 CT ORDER Form CT ORDER - Confidential treatment order
03/31/2017 CT ORDER Form CT ORDER - Confidential treatment order
07/15/2016 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
07/08/2016 EFFECT Form EFFECT - Notice of Effectiveness
07/08/2016 EFFECT Form EFFECT - Notice of Effectiveness
07/08/2016 EFFECT Form EFFECT - Notice of Effectiveness
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
07/05/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
07/05/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
07/01/2016 8-K Quarterly results
06/24/2016 8-K Form 8-K - Current report
06/21/2016 8-K Form 8-K - Current report
06/21/2016 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/21/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
06/16/2016 8-K Form 8-K - Current report
06/16/2016 SC 13D/A LANSDOWNE PARTNERS AUSTRIA GMBH reports a 8% stake in Alexza Pharmaceuticals, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy